Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax in HIV-positive individuals (PROVE-IT)
NCT01213810Phase 2Withdrawn
- Sponsor
- University of Zurich
- Start
- Dec 2010
- Primary completion
- Dec 2011
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 2 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by University of Zurich. Planned start Dec 2010; status: withdrawn.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01213810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01213810.